Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Omadacycline in Cystic Fibrosis
NCT04460586Phase 4Completed
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omadacycline in cystic fibrosis (CF). Started Jul 2021; status: completed.
02
Drugs
omadacycline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04460586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460586.